- Marble Hill fires entire sewer department (8/23/16)3
- Witness says he saw man shoot Domorlo McCaster (8/19/16)2
- Students move into new fraternity housing at Southeast Missouri State University (8/18/16)2
- Southeast imposes 'interim suspension' of Sigma Nu fraternity over vandalism incident (8/19/16)21
- Ex-Southeast student gets probation for placing homemade sex video on porn site without woman's knowledge (8/24/16)4
- The Chrome Queens (8/21/16)2
- Pitmasters to descend on Arena Park for Cape BBQ Fest (8/19/16)2
- Logan's Roadhouse in Cape not closing; Ruby Tuesday fate still unknown (8/17/16)
- Local private school dreams bigger, plans for new building at Sprigg and Lexington (8/22/16)
- Gender-neutral restrooms now available at Southeast (8/18/16)38
FDA requires new labels on HRT products
WASHINGTON -- The government announced new warnings Wednesday on the labels for hormone replacement therapies and advised millions of post-menopausal women to consult their doctors about whether to continue treatment.
The Food and Drug Administration acted after reviewing data from a landmark study that found that the increased risk of heart disease and breast cancer from using therapies combining the hormones estrogen and progestin far outweighed any health benefits. The government abruptly halted that study last July.
The FDA approved new labels for Wyeth Pharmaceuticals that includes a new boxed warning highlighting the increased risk for heart disease, heart attacks, strokes and breast cancer. They also include a reference to the study findings.
The new labels also emphasize that these products are not approved for the prevention of heart disease.
The FDA also said it was asking all manufacturers of estrogen and estrogen-progestin products to add similar warnings and change the enclosed patient information leaflet because all hormone products are believed to carry similar health risks.